Today, xCures announced their collaboration with CancerCompass, allowing consumers who contact CancerCompass to access the xCures’ platform and services.Consumers who purchase xCures’ comprehensive cancer case review service benefit from the xCures team organizing and structuring their medical records into high quality “Cancer Journey” patient summaries. These summaries are reviewed by xCures’ clinical scientists and utilized to identify appropriate treatment possibilities. For this, a proprietary options library, encompassing a highly curated set of novel therapies and multi-drug combinations vetted by leading oncologists and cancer scientists, will be referenced. xCures provides each patient with a summary report, suitable for sharing with their oncologist, consisting of a case summary, a list of top options, the rationale supporting each recommendation, and how to access the options.
“xCures partnering with CancerCompass is a significant step toward improving access to personalized knowledge about advanced cancer treatment options,” stated Mika Newton, xCures’ CEO. “This is important progress in our mission to broaden the availability of our comprehensive cancer case review services, positively affecting the largest number of cancer patients and their physicians.” Read more here.